• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

职业性中毒与膜性肾病。

Toxic Occupational Exposures and Membranous Nephropathy.

机构信息

Reference Center for Rare Diseases Idiopathic Nephrotic Syndrome, Nice University Hospital, Nice, France.

Clinical Research Unit Côte d'Azur, University Côte d'Azur, Nice, France.

出版信息

Clin J Am Soc Nephrol. 2022 Nov;17(11):1609-1619. doi: 10.2215/CJN.02930322. Epub 2022 Oct 25.

DOI:10.2215/CJN.02930322
PMID:36283759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9718038/
Abstract

BACKGROUND AND OBJECTIVES

Membranous nephropathy is a rare autoimmune kidney disease whose increasing prevalence in industrialized countries pleads for the involvement of an environmental factor in the development of the disease. In addition, the predominance of men in membranous nephropathy, classically attributed to biologic or genetic differences between men and women, could also be due to different occupational exposures. To support this hypothesis, we sought to describe the toxic occupational exposures of patients with membranous nephropathy.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this observational epidemiologic study, we compared the occupations and toxic occupational exposures of 100 patients with membranous nephropathy with those of the general population, consisting of two cohorts of 26,734,000 and 26,500 French workers. We then compared the characteristics of patients exposed to an occupational toxic substance with those of unexposed patients.

RESULTS

Patients with membranous nephropathy worked more frequently in the construction sector than the general population (33% versus 7%, <0.001). This difference remained significant by age and sex. They were also more frequently exposed to toxic substances, such as asbestos (16% versus 5%, <0.001), lead (9% versus 1%, <0.001), or organic solvents (37% versus 15%, <0.001), than the general population. The predominance of men in the subgroup of patients occupationally exposed to toxic substances was not observed in unexposed individuals (organic solvents: 80% men versus 41%, <0.001; asbestos: 90% men versus 55%, =0.004). In addition, patients with phospholipase A2 receptor 1 (PLA2R1) epitope spreading were more frequently exposed to asbestos and organic solvents than patients without epitope spreading (32% versus 7%, =0.02 and 74% versus 43%, =0.02, respectively), with a dose-dependent effect.

CONCLUSIONS

Patients with membranous nephropathy were more frequently exposed to certain occupational toxic substances, such as asbestos and organic solvents, than the general population. This occupational exposure was more frequent in men and in patients with PLA2R1 epitope spreading.

CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER

Immunopathological Analysis in a French National Cohort of Membranous Nephropathy (IHMN), NCT04326218.

PODCAST

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_10_25_CJN02930322.mp3.

摘要

背景和目的

膜性肾病是一种罕见的自身免疫性肾脏疾病,其在工业化国家的发病率不断上升,表明环境因素在疾病的发生发展中发挥了作用。此外,膜性肾病中男性的患病率较高,这一现象通常归因于男性和女性之间的生物学或遗传差异,但也可能与不同的职业暴露有关。为了支持这一假设,我们试图描述膜性肾病患者的有毒职业暴露情况。

方法

在这项观察性的流行病学研究中,我们将 100 名膜性肾病患者的职业和有毒职业暴露情况与普通人群进行了比较,普通人群由两个队列组成,分别包含 26734000 名和 26500 名法国工人。然后,我们比较了暴露于职业性有毒物质的患者和未暴露于有毒物质的患者的特征。

结果

膜性肾病患者比普通人群更频繁地从事建筑行业(33%比 7%,<0.001)。这种差异在年龄和性别上均有显著性。他们也更频繁地接触有毒物质,如石棉(16%比 5%,<0.001)、铅(9%比 1%,<0.001)或有机溶剂(37%比 15%,<0.001)。与普通人群相比,在暴露于有毒物质的患者亚组中,男性的比例较高,但在未暴露于有毒物质的个体中,这种情况并未观察到(有机溶剂:80%男性比 41%,<0.001;石棉:90%男性比 55%,=0.004)。此外,与无表位扩展的患者相比,磷脂酶 A2 受体 1(PLA2R1)表位扩展的患者更频繁地接触到石棉和有机溶剂(32%比 7%,=0.02;74%比 43%,=0.02),且具有剂量依赖性效应。

结论

与普通人群相比,膜性肾病患者更频繁地接触某些职业性有毒物质,如石棉和有机溶剂。这种职业暴露在男性和 PLA2R1 表位扩展的患者中更为常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e6/9718038/f629af887448/CJN.02930322absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e6/9718038/f629af887448/CJN.02930322absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71e6/9718038/f629af887448/CJN.02930322absf1.jpg

相似文献

1
Toxic Occupational Exposures and Membranous Nephropathy.职业性中毒与膜性肾病。
Clin J Am Soc Nephrol. 2022 Nov;17(11):1609-1619. doi: 10.2215/CJN.02930322. Epub 2022 Oct 25.
2
Clinical Relevance of Domain-Specific Phospholipase A Receptor 1 Antibody Levels in Patients with Membranous Nephropathy.膜性肾病患者特异性磷脂酶 A 受体 1 抗体水平的临床意义。
J Am Soc Nephrol. 2020 Jan;31(1):197-207. doi: 10.1681/ASN.2019030273. Epub 2019 Dec 16.
3
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.高剂量利妥昔单抗治疗 PLA2R1 相关膜性肾病的早期缓解作用。
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24.
4
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.磷脂酶 A2 受体 1 表位在基线时的扩展预示着膜性肾病缓解的可能性降低。
J Am Soc Nephrol. 2018 Feb;29(2):401-408. doi: 10.1681/ASN.2017070734. Epub 2017 Nov 7.
5
Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".作者回复:Mezei 等人的“对近期心包恶性间皮瘤和睾丸鞘膜病例对照研究的评论”。
Scand J Work Environ Health. 2021 Jan 1;47(1):87-89. doi: 10.5271/sjweh.3910. Epub 2020 Jul 7.
6
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.抗磷脂酶A2受体自身抗体反应的表位扩展与膜性肾病的不良预后相关。
J Am Soc Nephrol. 2016 May;27(5):1517-33. doi: 10.1681/ASN.2014111061. Epub 2015 Nov 13.
7
[Membranous nephropathy: Pathophysiology and natural history].[膜性肾病:病理生理学与自然史]
Nephrol Ther. 2017 Apr;13 Suppl 1:S75-S81. doi: 10.1016/j.nephro.2017.01.012.
8
Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.对近期一篇关于心包恶性间皮瘤和睾丸鞘膜的病例对照研究的评论。
Scand J Work Environ Health. 2021 Jan 1;47(1):85-86. doi: 10.5271/sjweh.3909. Epub 2020 Jul 6.
9
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.多自身抗体特征与膜性肾病的临床结局。
Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1762-1776. doi: 10.2215/CJN.02500220. Epub 2020 Nov 30.
10
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.原发性膜性肾病患者的M型磷脂酶A2受体自身抗体与肾功能
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.

引用本文的文献

1
Performance of Current Chronic Kidney Disease Screening Criteria in Women and Men Across Ethnic Groups: The HELIUS Study.当前慢性肾脏病筛查标准在不同种族男女中的表现:HELIUS研究
Mayo Clin Proc Innov Qual Outcomes. 2025 Apr 17;9(3):100613. doi: 10.1016/j.mayocpiqo.2025.100613. eCollection 2025 Jun.
2
Acute Kidney Injury and Nephrotic Syndrome in a Man Ingesting Traditional Indigenous Medications.一名服用传统本土药物的男性出现急性肾损伤和肾病综合征
Kidney360. 2025 Apr 1;6(4):673-675. doi: 10.34067/KID.0000000655.
3
NELL-1 as a Target Antigen in Asbestosis Associated Membranous Nephropathy - A Case Report.

本文引用的文献

1
Helper T Cells in Idiopathic Membranous Nephropathy.特发性膜性肾病中的辅助性 T 细胞。
Front Immunol. 2021 May 20;12:665629. doi: 10.3389/fimmu.2021.665629. eCollection 2021.
2
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy.Th17/Treg 比值改变作为特发性膜性肾病发病机制的一种可能机制。
Cytokine. 2021 May;141:155452. doi: 10.1016/j.cyto.2021.155452. Epub 2021 Feb 8.
3
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.
Nell-1作为石棉沉着病相关性膜性肾病的靶抗原——病例报告
Indian J Nephrol. 2025 Jan-Feb;35(1):103-105. doi: 10.25259/IJN_65_2024. Epub 2024 Jun 4.
4
Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target.免疫介导性肾小球肾炎中的表位扩展:不断扩大的靶标。
Int J Mol Sci. 2024 Oct 16;25(20):11096. doi: 10.3390/ijms252011096.
5
Bibliometric and visual analysis of membranous nephropathy literature from 2010 to 2023.2010年至2023年膜性肾病文献的文献计量学与可视化分析
Front Pharmacol. 2024 Sep 12;15:1426897. doi: 10.3389/fphar.2024.1426897. eCollection 2024.
6
Therapeutic targets in membranous nephropathy: plasma cells and complement.膜性肾病的治疗靶点:浆细胞与补体
Clin Kidney J. 2024 Aug 13;17(9):sfae243. doi: 10.1093/ckj/sfae243. eCollection 2024 Sep.
7
An Updated Review of Membranous Nephropathy.膜性肾病的最新综述
Indian J Nephrol. 2024 Mar-Apr;34(2):105-118. doi: 10.25259/ijn_317_23. Epub 2024 Apr 10.
8
Nephrotic Syndrome Associated With Heavy Metals Exposure: A Case Report and Literature Review.重金属暴露相关的肾病综合征:一例报告及文献综述
Cureus. 2024 Jan 10;16(1):e52029. doi: 10.7759/cureus.52029. eCollection 2024 Jan.
9
Monogenic and polygenic concepts in chronic kidney disease (CKD).单基因和多基因概念在慢性肾脏病(CKD)中的应用。
J Nephrol. 2024 Jan;37(1):7-21. doi: 10.1007/s40620-023-01804-8. Epub 2023 Nov 21.
膜性肾病患者的 Th17 免疫反应与血栓形成和复发有关。
Front Immunol. 2020 Nov 26;11:574997. doi: 10.3389/fimmu.2020.574997. eCollection 2020.
4
Toward Understanding of Environmental Risk Factors in Systemic Sclerosis [Formula: see text].系统性硬化症的环境风险因素研究进展[公式:见正文]。
J Cutan Med Surg. 2021 Mar-Apr;25(2):188-204. doi: 10.1177/1203475420957950. Epub 2020 Sep 28.
5
Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response.髓源性抑制细胞通过增强 Th17 反应促进原发性膜性肾病的进展。
Front Immunol. 2020 Aug 20;11:1777. doi: 10.3389/fimmu.2020.01777. eCollection 2020.
6
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.膜性肾病的遗传结构及其对改善非侵入性诊断的潜力。
Nat Commun. 2020 Mar 30;11(1):1600. doi: 10.1038/s41467-020-15383-w.
7
Immune-Monitoring Disease Activity in Primary Membranous Nephropathy.原发性膜性肾病中免疫监测疾病活动情况
Front Med (Lausanne). 2019 Nov 8;6:241. doi: 10.3389/fmed.2019.00241. eCollection 2019.
8
Management of Membranous Nephropathy after MENTOR.MENTOR后膜性肾病的管理
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):415-417. doi: 10.2215/CJN.10240819. Epub 2019 Nov 18.
9
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?表位扩展是否影响磷脂酶A2受体相关膜性肾病对利妥昔单抗的反应性?
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1122-1124. doi: 10.2215/CJN.07300619. Epub 2019 Jul 24.
10
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.高剂量利妥昔单抗治疗 PLA2R1 相关膜性肾病的早期缓解作用。
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24.